LEAD FOR PEDIATRIC CHOLESTEROL SCREENING Trademark

Charitable services, namely, promoting public awareness of improving health outcomes for individuals and families at highest risk of primary and secondary atherosclerotic cardiovascular disease (ASCVD) due to genetic drivers of ASCVD risk, namely familial hypercholesterolemia (FH), elevated Lipoprotein(a) (Lp(a)) and polygenic lipid disorders; Charitable services, namely, promoting public awareness of universal screening in children for lipid disorders; Charitable services, namely, promoting public awareness of universal pediatric lipid screening to diagnose children and adolescents with FH and initiate early treatment; Charitable services, namely, promoting public awareness of preventing premature disease and mortality due to ASCVD, and reducing the number of early ASCVD preventable deaths by early diagnosis and treatment; Charitable services, namely, promoting public awareness of pediatric targeted screening to those with family history of premature heart disease and significantly abnormal cholesterol.; Charitable services, namely, promoting public awareness of the health benefits of early childhood cholesterol screening to assist clinicians in diagnosing children and adolescents with FH and provide guidance and early treatment